The peroxisome proliferator-activated receptorγ (PPARγ) as a regulator of monocyte/macrophage function

Journal of Leukocyte Biology

Volumn 66, Issue 5, 1999, Pages 733-739

  Ricote, Mercedes ^a   Huang, Jannet T ^b   Welch, John S ^a   Glass, Christopher K ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Inflammatory response; Nuclear receptor; Transcription factors

Indexed keywords

FATTY ACID; HORMONE RECEPTOR; ICOSANOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROID RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

ATHEROSCLEROSIS; CONFERENCE PAPER; GENE CONTROL; GLUCOSE HOMEOSTASIS; INFLAMMATION; LIPID METABOLISM; MACROPHAGE FUNCTION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0032737858     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.5.733     Document Type: Conference Paper

References (86)

1. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schülz, G., Umesono, K., Blumberg, B., Kastner, R, Mark, M., Chambon, P., Evans, R. M. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
2. Chambon, P. (1995) The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog. Horm. Res. 50, 317-332.
3. Glass, C. K. (1994) Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocr. Rev. 15, 1503-1519.
4. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., Evans, R. M. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774.
5. Bardot, O., Aldridge, T. C., Latruffe, N., Green, S. (1993) PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun. 192, 37-45.
6. Gearing, K. L., Gottlicher, M., Teboul, M., Widmark, E., Gustafsson, J. A. (1993) Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA 90, 1440-1444.
7. Issemann, I., Prince, R. A., Tugwood, J. D., Green, S. (1993) The peroxisome proliferator-activated receptor retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11, 37-47.
8. Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., Evans, R. M. (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91, 7355-7359.
9. Wahli, W., Braissant, O., Desvergne, B. (1995) Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol. 2, 261-266.
10. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., Wahli, W. (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, -γ in the adult rat. Endocrinol. 137, 354-366.
11. Schoonjans, K., Staels, B., Auwerx, J. (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37, 907-925.
12. Lemberger, T., Desvergne, B., Wahli, W. (1996) PPARs: a nuclear receptor signaling pathway in lipid metabolism. Annu. Rev. Cell Dev. Biol. 12, 335-363.
13. Chawla, A., Schwartz, E. J., Dimaculangan, D. D., Lazar, M. A. (1994) Peroxisome proliferator-activated receptor γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinol. 135, 798-800.
14. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., Spiegelman, B. M. (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
15. Tontonoz, P., Hu, E., Spiegelman, B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147-1156.
16. Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., Kliewer, S. A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARgamma). J. Biol. Chem. 270, 12953-12956.
17. Willson, T. M., Cobb, J. E., Cowan, D. J., Wiethe, R. W., Correa, I. D., Prakash, S. R., Beck, K. D., Moore, L. B., Kliewer, S. A., Lehmann, J. M. (1996) The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39, 665-668.
18. Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., Reddy, J. K. (1995) Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc. Natl. Acad. Sci. USA 92, 7921-7925.
19. Fajas, L., Auboeuff, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., Vidal-Puig, A., Flier, J., Briggs, M. R., Staels, B., Vidal, H., Auwerx, J. (1997) The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem. 272, 18779-18789.
20. Vidal-Puig, A., Jimenez-Liñan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B., Flier, J. S., Moller, D. E. (1996) Regulation of PPARγ gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97, 2553-2561.
21. Mukherjee, R., Jow, L., Croston, G. E., Paterniti, J. R., Jr. (1997) Identification, characterization, and tissue distribution of human Peroxisome Proliferator-Activated Receptor (PPAR) isoforms PPAR-gamma2 versus PPAR-gammal and activation with Retinoid X Receptor agonists and antagonists. J. Biol. Chem. 272, 8071-8076.
22. Vidal-Puig, A. J., Considine, R. V., Jimenez-Liñan, M., Werman, A., Pories, W. J., Caro, J. F., Flier, J. S. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues: Effects of obesity, wieght loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99, 2416-2422.
23. Ricole, M., Li, A. C., Willson, T. M., Kelly, C. J., Glass, C. K. (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82.
24. Fajas, L., Fruchart, J. C., Auwerx, J. (1998) PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter. FEBS Lett. 438, 55-60.
25. Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J. L., Auwerx, J., Palinski, W., Glass, C. K. (1998) Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 95, 7614-7619.
26. Greene, M. E., Blumberg, B., McBride, O. W., Yi, H. F., Kronquist, K., Kwan, K., Hsieh, L., Greene, G., Nimer, S. D. (1995) Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expression 4, 281-299.
27. Jiang, C., Ting, A. T., Seed, B. (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
28. Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., Staels, B. (1998) Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273, 25573-25580.
29. Marx, N., Sukhova, G., Murphy, C., Libby, P., Plulzky, J. (1998) Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153, 17-23.
30. Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., Evans, R. M. (1998) PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252.
31. Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., Spiegelman, B. M. (1997) Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. USA 94, 237-241.
32. Altiok, S., Xu, M., Spiegelman, B. M. (1997) PPARα induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11, 1987-1998.
33. Kubota, T., Koshizuka, K., Williamson, E. A., Asou, H., Said, J. W., Holden, S., Miyoshi, I., Koeffler, H. P. (1998) Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res. 58, 3344-3352.
34. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., Spiegelman, B. M. (1998) Terminal differentiation of human breast cancer through PPARγ. Mol. Cell. 1, 465-470.
35. DuBois, R. N., Gupta, R., Brockman, J., Reddy, B. S., Krakow, S. L., Lazar, M. A. (1998) The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonie cancers. Carcinogenesis 19, 49-53.
36. Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., Evans, R. M. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR-gamma. Cell 93, 229-240.
37. Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., Lehman, J. M. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 94, 4318-4323.
38. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., Wahli, W. (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791.
39. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813-819.
40. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812.
41. Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., Milburn, M. V. (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395, 137-143.
42. Hu, E., Kim, J. B., Sarraf, P., Spiegelman, B. M. (1996) Inhibition of adipogenesis through Map Kinase-mediated phosphorylation of PPARγ. Science 274, 2100-2103.
43. Zhang, B., Berfer, J., Zhou, G., Elbrech, A., Biswas, S., White-Carrington, S., Szalkowski, D., Moller, D. E. (1996) Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ. J. Biol. Chem. 271, 31771-31774.
44. Adams, M., Reginato, M. J., Shao, D. S., Lazar, M. A., Chatterjee, V. K. (1997) Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132.
45. Camp, H. S., Tafuri, S. R. (1997) Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J. Biol. Chem. 272, 10811-10816.
46. Shao, D., Rangwala, S. M., Bailey, S. T., Krakow, S. L., Reginato, M. J., Lazar, M. A. (1998) Interdomain communication regulating ligand binding by PPAR-γ. Nature 396, 377-380.
47. DiRenzo, J., Söderström, M., Kurokawa, R., Ogliastro, M.-H., Ricote, M., Ingrey, S., Hörlein, A., Rosenfeld, M. G., Glass, C. K. (1997) Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators and compressors. Mol. Cell. Biol. 17, 2166-2176.
48. Zhu, Y., Qi, C., Jain, S., Rao, M. S., Reddy, J. K. (1997) Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem. 272, 25500-25506.
49. Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., Spiegelman, B. M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839.
50. Gelman, L., Zhou, G., Fajas, L., Raspe, E., Fruchart, J.-C., Auwerx, J. (1999) p300 interacts with the N- and C-terminal part of PPARγ2 in a ligand-independent and -dependent manner, respectively. J. Biol. Chem. 274, 7681-7688.
51. Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., Hisenbeck, S. G., Osborne, C. K., Glass, C. K., Rosenfeld, M. G., Rose, D. W. (1998) Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. USA 95, 2920-2925.
52. Janknecht, R., Hunter, T. (1996) A growing coactivator network. Nature 383, 22-23.
53. Glass, C. K., Rose, D. W., Rosenfeld, M. G. (1997) Nuclear receptor coactivators. Curr. Opin. Cell Biol. 9, 222-232.
54. Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., Rosenfeld, M. G. (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684.
55. Pazin, M. J., Kadonaga, J. T. (1997) What's up and down with histone deacetylation and transcription? Cell 89, 325-328.
56. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
57. Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M.-J., O'Malley, B. W. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389, 194-198.
58. Utley, R. T., Ikeda, K., Grant, P. A., Cote, J., Steger, D. J., Eberharter, E., John, S., Workman, J. L. (1998) Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature 394, 498-502.
59. Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringhold, G. M., Kliewer, S. A. (1997) Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406-3410.
60. Colville-Nash, P. R., Qureshi, S. S., Willis, D., Willoughby, D. A. (1998) Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase I. J. Immunol. 161, 978-984.
61. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
62. Ross, R. (1999) Atherosclerosis - an inflammatory disease. N. Engl. J. Med 340, 115-126.
63. Watanabe, T., Haraoka, S., Shimokama, T. (1996) Inflammatory and immunological nature of atherosclerosis. Int. J. Cardiol. 54, S51-S60.
64. Yokota, T., Hansson, G. K. (1995) Immunological mechanisms in atherosclerosis. J. Int. Med. 238, 479-189.
65. Libby, P., Hansson, G. K. (1991) Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest. 64, 5-15.
66. Krieger, M., Herz, J. (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63, 601-637.
67. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., Witztum, J. L. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915-924.
68. Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J., Hansson, G. K. (1995) T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 92, 3893-3897.
69. Lee, R. T., Libby, P. (1997) The unstable atheroma. Arterioscler. Thromb. Vasc. Biol. 17, 1859-1867.
70. Libby, P., Sukhova, G., Lee, R. T., Liao, J. K. (1997) Molecular biology of atherosclerosis. Int. J. Cardiol. 62, S23-S29.
71. Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., Protter, A. A. (1993) CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268, 11811-11816.
72. Abumrad, N. A., el-Maghrabi, M. R., Amri, E. Z., Lopez, E., Grimaldi, P. A. (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268, 17665-17668.
73. Marx, N., Scheonbeck, U., Lazar, M. A., Libby, P., Plutzky, J. (1998) Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res. 83, 1097-1103.
74. Shinohara, E., Kihara, S., Ouchi, N., Funahashi, T., Nakamura, T., Yamashita, S., Kameda-Takemura, K., Matsuzawa, Y. (1998) Troglitazone suppresses intimai formation following balloon injury in insulin-resistant Zucker fatty rats. Atherosclerosis 136, 275-279.
75. Law, R. E., Meehan, W. P., Xi, X.-P., Graf, K., Wuthrich, D. A., Coats, W., Faxon, D., Hsueh, W. A. (1996) Troglitazone inhibits vascular smooth muscle cell growth and intimai hyperplasia. J. Clin. Invest. 98, 1897-1905.
76. Gralinski, M. R., Rowse, P. E., Breider, M. A. (1998) Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro. J. Cardiovasc. Pharmacol. 31, 909-913.
77. Xin, X., Yang, S., Kowalski, J., Gerritsen, M. E. (1999) Peroxisome proliferalor-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo. J. Biol. Chem. 274, 9116-9121.
78. Inoue, I., Katayama, S., Takahashi, K., Negishi, K., Miyazaki, T., Sonoda, M., Komoda, T. (1997) Troglitazone has a scavenging effect on reactive oxygen species. Biochem. Biophys. Res. Commun. 235, 113-116.
79. Noguchi, N., Sakai, H., Kato, Y., Tsuchiya, J., Yamamoto, Y., Niki, E., Horikoshi, H., Kodama, T. (1996) Inhibition of oxidation of low density lipoprotein by troglitazone. Atherosclerosis 123, 227-234.
80. Ghazzi, M. N., Perez, J. E., Antonucci, T. K., Driscoll, J. H., Huang, S. M., Faja, B. W., Whitcomb, R. W. (1997) Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes 46, 433-439.
81. Minamikawa, J., Yamaguchi, M., Inoue, D., Koshiyama, H. (1998) Another potential use of Troglitazone in non-insulin dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83, 1041.
82. Mansen, A., Guardiola-Biaz, H., Rafter, J., Branting, C., Gustafsson, J.-A. (1996) Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Bicohem. Biophys. Res. Commun. 222, 844-851.
83. Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., Spiegelman, B. M. (1998) Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nature Med. 4, 1046-1052.
84. Elstner, E., Muller, C., Koshizuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D., Koeffler, P. (1998) Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human brest cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA 95, 8806-8811.
85. Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., U, T.M., Baird, S. M., Thomazy, V. A., Evans, R. M. (1998) Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nature Med. 4, 1058-1061.
86. Min/+ mice. Nature Med. 4, 1053-1057.